At close: December 13 at 1:30:34 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,471,325.00
3,929,887.00
3,168,680.00
2,570,866.00
2,342,226.00
Cost of Revenue
987,914.00
893,517.00
805,697.00
729,522.00
700,189.00
Gross Profit
3,483,411.00
3,036,370.00
2,362,983.00
1,841,344.00
1,642,037.00
Operating Expense
2,883,093.00
2,499,670.00
2,014,223.00
1,681,428.00
1,552,201.00
Operating Income
600,318.00
536,700.00
348,760.00
159,916.00
89,836.00
Net Non Operating Interest Income Expense
-34,506.00
-37,041.00
-19,714.00
-15,631.00
-27,253.00
Pretax Income
600,239.00
509,226.00
303,021.00
74,594.00
109,155.00
Tax Provision
141,450.00
120,917.00
79,440.00
21,717.00
7,843.00
Net Income Common Stockholders
454,186.00
384,201.00
221,533.00
52,271.00
101,828.00
Diluted NI Available to Com Stockholders
454,186.00
384,201.00
221,533.00
52,271.00
101,828.00
Basic EPS
4.84
4.50
2.84
0.37
1.00
Diluted EPS
4.74
4.18
2.51
0.37
0.94
Basic Average Shares
93,232.33
84,320.00
78,112.00
77,854.00
78,340.00
Diluted Average Shares
97,150.13
93,022.00
88,092.00
78,114.00
88,496.00
Total Expenses
3,871,007.00
3,393,187.00
2,819,920.00
2,410,950.00
2,252,390.00
Net Income from Continuing & Discontinued Operation
454,186.00
384,201.00
221,533.00
52,271.00
101,828.00
Normalized Income
448,380.81
379,191.83
221,467.33
51,201.32
101,789.02
Interest Income
8,971.00
7,101.00
4,392.00
2,010.00
4,133.00
Interest Expense
43,477.00
44,142.00
24,106.00
17,641.00
31,386.00
Net Interest Income
-34,506.00
-37,041.00
-19,714.00
-15,631.00
-27,253.00
EBIT
643,716.00
553,368.00
327,127.00
92,235.00
140,541.00
EBITDA
1,090,535.00
949,839.00
662,384.00
401,968.00
427,340.00
Reconciled Cost of Revenue
987,914.00
893,517.00
805,697.00
729,522.00
700,189.00
Reconciled Depreciation
446,819.00
396,471.00
335,257.00
309,733.00
286,799.00
Net Income from Continuing Operation Net Minority Interest
454,186.00
384,201.00
221,533.00
52,271.00
101,828.00
Total Unusual Items Excluding Goodwill
7,595.00
6,569.00
89.00
1,509.00
42.00
Total Unusual Items
7,595.00
6,569.00
89.00
1,509.00
42.00
Normalized EBITDA
1,082,940.00
943,270.00
662,295.00
400,459.00
427,298.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,789.81
1,559.83
23.33
439.32
3.02
12/31/2020 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4138.TWO Dynamic Medical Technologies Inc.
91.20
-0.87%
1781.TWO Health & Life Co., Ltd.
17.15
-3.11%
3218.TWO Universal Vision Biotechnology Co., Ltd.
207.00
-1.90%
4735.TWO AViTA Corporation
39.55
-2.83%
1788.TWO Hi-Clearance Inc.
139.50
0.00%
4121.TWO Rossmax International Ltd.
16.10
-2.42%
4161.TWO Bioptik Technology Incorporation
33.30
-1.77%
4188.TWO AmCad BioMed Corporation
21.70
+0.70%
4745.TWO Cowealth Medical Holding Co., Ltd.
20.30
-1.22%
6767.TWO Wiltrom Co., Ltd.
32.75
+0.46%